Abstract
Keywords
Publication details
- DOI
- 10.4103/ojo.ojo_335_21
- Journal
- Oman Journal of Ophthalmology, 15(2), 255-257
- Publisher
- Medknow Publications
- Open access
- Gold open access
Cite this article
APA 7
Kaufman, A. R., & Kang, K. B. (2022). Iodine-125 plaque brachytherapy for aggressive squamous cell carcinoma with corneal and scleral invasion. Oman Journal of Ophthalmology, 15(2), 255-257. https://doi.org/10.4103/ojo.ojo_335_21
MLA 9
Kaufman, Aaron R, and Kai B Kang. "Iodine-125 plaque brachytherapy for aggressive squamous cell carcinoma with corneal and scleral invasion." Oman Journal of Ophthalmology, vol. 15, no. 2, 2022, pp. 255-257. https://doi.org/10.4103/ojo.ojo_335_21.
Chicago (author–date)
Kaufman, Aaron R, and Kai B Kang. 2022. "Iodine-125 plaque brachytherapy for aggressive squamous cell carcinoma with corneal and scleral invasion." Oman Journal of Ophthalmology 15 (2): 255-257. https://doi.org/10.4103/ojo.ojo_335_21.
Harvard
Kaufman, A. R. and Kang, K. B. (2022) 'Iodine-125 plaque brachytherapy for aggressive squamous cell carcinoma with corneal and scleral invasion', Oman Journal of Ophthalmology, 15(2), pp. 255-257. doi:10.4103/ojo.ojo_335_21.
Vancouver
Kaufman AR, Kang KB. Iodine-125 plaque brachytherapy for aggressive squamous cell carcinoma with corneal and scleral invasion. Oman Journal of Ophthalmology. 2022;15(2):255-257. doi:10.4103/ojo.ojo_335_21
IEEE
A. R. Kaufman, and K. B. Kang, "Iodine-125 plaque brachytherapy for aggressive squamous cell carcinoma with corneal and scleral invasion," Oman Journal of Ophthalmology, vol. 15, no. 2, pp. 255-257, 2022, doi: 10.4103/ojo.ojo_335_21.